Literature DB >> 10666382

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

P Auvinen1, R Tammi, J Parkkinen, M Tammi, U Agren, R Johansson, P Hirvikoski, M Eskelinen, V M Kosma.   

Abstract

Hyaluronan (HA) is an extracellular matrix polysaccharide that promotes cell migration through its cell surface receptors and by effecting changes in the physical environment. HA expression is frequently increased in malignant tumors, whereas its association with the invasive potential and patient outcome in breast cancer has not been reported. The localization and signal intensity of HA was analyzed in 143 paraffin-embedded tumor samples of human breast carcinoma using a biotinylated HA-specific probe. In the immediate peritumoral stroma, HA signal was moderately or strongly increased in 39% and 56% of the cases, respectively. Normal ductal epithelium showed no HA, whereas in 57% of the tumors at least some of the carcinoma cells were HA positive. The intensity of the stromal HA signal and the presence of cell-associated HA were both significantly related to poor differentiation of the tumors, axillary lymph node positivity, and short overall survival of the patients. In Cox's multivariate analysis, both the intensity of stromal HA signal alone and that combined with the HA positivity in tumor cells were independent prognostic factors for overall survival. These results suggest that HA is directly involved in the spreading of breast cancer and may offer a potential target for new therapies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666382      PMCID: PMC1850058          DOI: 10.1016/S0002-9440(10)64757-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.

Authors:  M Culty; M Shizari; E W Thompson; C B Underhill
Journal:  J Cell Physiol       Date:  1994-08       Impact factor: 6.384

Review 2.  Hyaluronan synthases.

Authors:  P H Weigel; V C Hascall; M Tammi
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

3.  Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.

Authors:  K Ropponen; M Tammi; J Parkkinen; M Eskelinen; R Tammi; P Lipponen; U Agren; E Alhava; V M Kosma
Journal:  Cancer Res       Date:  1998-01-15       Impact factor: 12.701

4.  Immunohistochemical localization of extracellular matrix components in human breast tumours with special reference to PG-M/versican.

Authors:  Y Nara; Y Kato; Y Torii; Y Tsuji; S Nakagaki; S Goto; H Isobe; N Nakashima; J Takeuchi
Journal:  Histochem J       Date:  1997-01

5.  Expression of lumican in human breast carcinoma.

Authors:  E Leygue; L Snell; H Dotzlaw; K Hole; T Hiller-Hitchcock; P J Roughley; P H Watson; L C Murphy
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma.

Authors:  M de la Torre; A F Wells; J Bergh; A Lindgren
Journal:  Hum Pathol       Date:  1993-12       Impact factor: 3.466

7.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

8.  Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.

Authors:  K Beckenlehner; S Bannke; T Spruss; G Bernhardt; H Schönenberg; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 9.  The role and regulation of tumour-associated hyaluronan.

Authors:  W Knudson; C Biswas; X Q Li; R E Nemec; B P Toole
Journal:  Ciba Found Symp       Date:  1989

10.  Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate.

Authors:  L P Setälä; M I Tammi; R H Tammi; M J Eskelinen; P K Lipponen; U M Agren; J Parkkinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  143 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

Review 2.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

3.  Localised breast cancers may have systemic influences on skin and hair.

Authors:  James S Lawson; Dinh D Tran
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

4.  In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy.

Authors:  S H Chung; A E Cerussi; C Klifa; H M Baek; O Birgul; G Gulsen; S I Merritt; D Hsiang; B J Tromberg
Journal:  Phys Med Biol       Date:  2008-11-07       Impact factor: 3.609

5.  Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.

Authors:  Tímea Váradi; Tamás Mersich; Päivi Auvinen; Raija Tammi; Markku Tammi; Ferenc Salamon; István Besznyák; Ferenc Jakab; Zsolt Baranyai; János Szöllősi; Peter Nagy
Journal:  J Histochem Cytochem       Date:  2012-05-04       Impact factor: 2.479

6.  Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan.

Authors:  Aditya G Kohli; Saul Kivimäe; Matthew R Tiffany; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-20       Impact factor: 9.776

7.  Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Authors:  Berit Bernert; Helena Porsch; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

8.  A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.

Authors:  Nabil Mohie Abdel-Hamid; M M Abouzied; M H Nazmy; M A Fawzy; A S Gerges
Journal:  Tumour Biol       Date:  2015-09-19

Review 9.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

Review 10.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.